![GeneAb<sup>TM</sup> VHL [IHC683] on Kidney Coming Soon](../../images/GeneAb/AntigensProductImages/Coming_Soon.png)
![GeneAb<sup>TM</sup> VHL [IHC683] on Kidney Coming Soon](../../images/GeneAb/AntigensThumbnails/Coming_Soon.png)
Designations
IVD: RUO:
Reference Panels
Breast/Gynecological Pathology
Dermatopathology
Gastrointestinal (GI) Pathology
Genitourinary (GU) Pathology
Head and Neck Pathology
Hematopathology
Neuropathology
Pediatric Pathology
Pulmonary Pathology
Soft Tissue Pathology
Cytopathology
GeneAb™
VHL
(In the pipeline)Select Format:
Select Volume:
Price:
$210.00
Quantity:
Cat. No.
IHC683-100
Description
Von Hippel–Lindau tumor suppressor (VHL) is a protein whose mutated form leads to von Hippel–Lindau disease, which is characterized by an upregulation of angiogenesis related factors. VHL is associated with central nervous system hemangioblastomas, clear cell renal carcinomas, and pheochromocytomas.
Specifications
| Clone | IHC683 |
| Source | Mouse Monoclonal |
| Positive Control | Colon and Thyroid Cancer Tissue |
| Dilution Range | 1:100 - 1:200 |
IFU & SDS
References
- Esteban MA, et al. J Am Soc Nephrol. 2006; 17:1801-6.
- Kaelin WG. Clin Cancer Res. 2007; 13:680s-684s.
Follow Us
